[Results of the treatment of Hodgkin's disease stage III and IV using the ABVD and BACOP programs].
作者信息
Leszko B, Słomkowski M, Przybyszewska M, Apel D, Pawelski S
出版信息
Acta Haematol Pol. 1986 Jul-Dec;17(3-4):81-90.
PMID:2438894
Abstract
摘要
相似文献
1
[Results of the treatment of Hodgkin's disease stage III and IV using the ABVD and BACOP programs].
Acta Haematol Pol. 1986 Jul-Dec;17(3-4):81-90.
2
MOPP, ABVD, or both to treat Hodgkin's disease.
N Engl J Med. 1993 Apr 8;328(14):1045; author reply 1045-6. doi: 10.1056/NEJM199304083281417.
3
Long-term follow-up of survival in Hodgkin's lymphoma.
N Engl J Med. 2009 Dec 10;361(24):2390-1. doi: 10.1056/NEJMc0906731.
4
Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.
Cancer Treat Res. 1989;41:241-6.
5
Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
Anticancer Res. 2010 Oct;30(10):4381-7.
6
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Anticancer Res. 2009 Feb;29(2):777-83.
7
[Cardiogenic shock during polychemotherapy in a patient with Hodgkin's disease].
Kardiol Pol. 1986;29(8):555-9.
8
Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.
Ann Hematol. 2004 Mar;83(3):176-82. doi: 10.1007/s00277-003-0727-9. Epub 2003 Dec 12.
9
10
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
Cancer Treat Rep. 1987 Dec;71(12):1203-7.
Zotero 插件